Clinical predictors of long-term survival in HER2-positive metastatic breast cancer-Reference-Cited by-同舟云学术

Clinical predictors of long-term survival in HER2-positive metastatic breast cancer

Published:2016-02 Issue:3 Volume:155 Page:589-595
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Murthy Pooja,Kidwell Kelley M.,Schott Anne F.,Merajver Sofia D.,Griggs Jennifer J.,Smerage Jeffrey D.,Van Poznak Catherine H.,Wicha Max S.,Hayes Daniel F.,Henry N. Lynn

Funder

National Cancer Institute

Breast Cancer Research Foundation

Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes on Sale

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3705-3.pdf

Reference19 articles.

1. Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F et al (2009) High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol 27(34):5700–5706. doi: 10.1200/JCO.2009.23.2025

2. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785):177–182

3. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM et al (1999) Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17(9):2639–2648

4. Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, Giordano SH (2009) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28(1):92–98. doi: 10.1200/JCO.2008.19.9844

5. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L et al (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353(16):1659–1672

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer: insights from real-world data of a nationwide cohort;2024-05-15

2. Investigating The Correlation Between Prolonged Survival In Patients With Advanced HER2+ Breast Cancer And The Activity Of Regulatory T Cells.;2024-03-18

3. Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba;American Journal of Clinical Oncology;2023-12-04

4. Low-Dose Radiosurgery for Brain Metastases in the Era of Modern Systemic Therapy;Neurosurgery;2023-06-16

5. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry;ESMO Open;2023-06